FDAMarch 27, 2024drug
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Official recall recorded by the U.S. Food & Drug Administration.
The hazard
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
What to do
FDA enforcement status: Completed
Brands named
esperion
Recall history
Other federal recalls tied to the same brand — a factual pattern, straight from the source data.
Own something like this?
AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.
Start free — 200 items, no card →